Cardinal Health, Inc. operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cardinal Health with three other
drug stores in North America:
McKesson Corporation
(2021
sales of $238.23 billion
of which 79%
was U.S. Pharmaceutical),
Walgreens Boots Alliance Inc
($132.51 billion
of which 85%
was Retail Pharmacy USA), and
Rite Aid Corporation
($24.04 billion
of which 68%
was Retail pharmacy).
Sales Analysis.
During the second
calendar
quarter of 2021, sales at Cardinal Health totalled
$42.59 billion.
This is
an increase of 16.1%
from the $36.69 billion in sales at the company during the second quarter of 2020.
This was the largest same quarter increase in sales since the first
calendar
quarter of 2016.
During the first two
calendar
quarters of 2021, sales totalled $81.86 billion, which is
7.9% higher
than through the first two quarters of 2020.
There appears to be at least some degree of seasonality in the sales at Cardinal Health: during 7 of the previous 8
calendar
years, sales were highest during the fourth quarter.
The exception to this was during 2013, when the
second quarter was the best quarter, accounting for
26% of sales (during that same year, the
fourth quarter accounted for 23% of sales).
Cardinal Health reported sales of $162.47 billion
for the
fiscal
year ending
June of 2021.
This
represents
an
increase of 6.2%
versus 2020, when the company's sales were $152.92 billion.
Sales at Cardinal Health have increased during each of the previous five years
(and since 2016, sales have increased a total of 34%).
Sales of Medical saw an increase
of
8.0% in 2021, from
$15.44 billion to $16.69 billion.